Effects of the 5-HT3 receptor antagonist ondansetron on the ketamine- and dizocilpine-induced place preferences in mice

European Journal of Pharmacology

Volumn 385, Issue 2-3, 1999, Pages 99-102

  Suzuki, Tsutomu ^a   Aoki, Takeshi ^a   Kato, Hideaki ^a   Yamazaki, Mitsuaki ^b   Misawa, Miwa ^a  

^a HOSHI UNIVERSITY   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Conditioned place preference; Dizocilpine; Ketamine; Ondansetron

Indexed keywords

DIZOCILPINE; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; ONDANSETRON; SEROTONIN; SEROTONIN 3 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; CONDITIONING, OPERANT; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; KETAMINE; MALE; MICE; ONDANSETRON; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN ANTAGONISTS;

EID: 0032779143     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00762-1     Document Type: Article

References (21)

1. Avenet P., Léonardon J., Besnerd F., Graham D., Depoortere H., Scatton B. Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes. Neurosci. Lett. 223:1997;133-136.
2. 3 receptor antagonists block morphine- and nicotine-induced place-preference conditioning. Eur. J. Pharmacol. 151:1988;159-160.
3. 3 antagonist on drug-induced stimulation of dopamine release. Eur. J. Pharmacol. 164:1989;515-519.
4. Del Pozo E., Barrios M., Baeyens J.M. The NMDA receptor antagonist dizocilpine (MK-801) stereoselectively inhibits morphine-induced place preference conditioning in mice. Psychopharmacology. 125:1996;209-213.
5. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synapse dopamine concentrations in the mesolimbic system of moving rats. Proc. Natl. Acad. Sci. U.S.A. 85:1988;5274-5278.
6. 3 receptors control dopamine release in the nucleus accumbens of freely moving rats. Neurosci. Lett. 101:1989;214-217.
7. Irifune M., Fukuda T., Nomoto M., Sato T., Kamata Y., Nishikawa T., Mietani W., Yokoyama K., Sugiyama K., Kawahara M. Effects of ketamine on dopamine metabolism during anesthesia in discrete brain regions in mice: comparison with the effects during the recovery and subanesthetic phases. Brain Res. 763:1997;281-284.
8. Kamaya H., Krishna P.R. Ketamine addiction. Anesthesiology. 67:1987;861-862.
9. 3 receptor antagonist MDL 72222 dose-dependently attenuates cocaine- and amphetamine-induced elevations of extracellular dopamine in the nucleus accumbens and the dorsal striatum. Pharmacol. Toxicol. 78:1996;317-321.
10. Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomei H., Burnashev N., Sakmann B., Seeburg P.H. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science. 256:1992;1217-1221.
11. Moreton J.E., Meisch R.A., Stark L., Thompson T. Ketamine self-administration by the rhesus monkey. J. Pharmacol. Exp. Ther. 203:1977;303-309.
12. Steinpreis R.E., Salamone J.D. The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microdialysis and behavioral study. Brain Res. 612:1993;263-270.
13. Sukhotina I., Dravolina O., Bespalov A. Place conditioning of mice with the NMDA receptor antagonists, eliprodil and dizocilpine. Eur. J. Pharmacol. 362:1998;103-110.
14. Suzuki T., Masukawa Y., Misawa M. Drug interactions in the reinforcing effects of over-the-counter cough syrups. Psychopharmacology. 102:1990;438-442.
15. 3 receptor antagonists block cocaine- and methamphetamine-induced place preference. Jpn. J. Psychopharmacol. 12:1992;33-38.
16. Suzuki T., Kato H., Tsuda M., Suzuki H., Misawa M. Effects of the non-competitive NMDA receptor antagonist ifenprodil on the morphine-induced place preference in mice. Life Sci. 64:1999;151-156.
17. Tzschentke T.M., Schmidt W.J. N-Methyl-D-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats. Neurosci. Lett. 193:1995;37-40.
18. 3 receptor antagonist, reduces cocaine's psychomotor stimulant effects in the rat. Psychopharmacology. 101:1990;S59.
19. Verney M.A., Jachec C., Deal C., Hess S.D., Daggett L.P., Skvoretz R., Urcan M., Morrison J.H., Moran T., Johonson E.C., Velicelebi G. Stable expression and characterization of recombinant human heteromeric N-methyl-D-aspartate receptor subtypes NMDAR1A/2A and NMDAR1A/2B in mammalian cells. J. Pharmacol. Exp. Ther. 279:1996;367-378.
20. Williams K. Ifenprodil discriminates subtypes of the N-Methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol. Pharmacol. 44:1993;851-859.
21. Yang C.-Y., Wong C.-S., Chang J.-Y., Ho S.-T. Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain. Can. J. Aneasth. 43:1996;379-383.